Professional Documents
Culture Documents
tmpC47C TMP
tmpC47C TMP
ABSTRACT
Objective: To establish the usefulness of grading system based on the size and extent of corneal involvement in predicting
recurrence in patients undergoing primary pterygium excision with intraoperative use of adjunctive topical Mitomycin-C
(MMC).
Study Design: A case series.
Place and Duration of Study: Section of Ophthalmology, the Aga Khan University Hospital, Karachi, from 2005 till 2010.
Methodology: One hundred and twenty male patients (120 eyes) underwent surgical removal of pterygium using bare
sclera method with MMC in concentration of 0.2 mg/ml (0.02%) with exposure time of 3 minutes. Classification of subjects
was done according to the grading of pterygium. Patients were followed at 3 months interval for a minimum period of 1
year to record any recurrence.
Results: The pterygium recurrence rate was 6.7% at a follow-up of 1 year. There was no significant association of
pterygium recurrence with younger age (p = 0.14). A higher level of corneal involvement by the pterygium at presentation
correlated significantly with the recurrence (p = 0.01).
Conclusion: These results suggest that a higher grade of pterygium at presentation in patients leads to increased rate of
recurrence after surgical excision. Hence, early excision of pterygium is recommended to decrease its recurrence rate.
Key words:
INTRODUCTION
Pterygium is one of the most common conjunctival
surface degenerative disorders.1-3 This fibrovascular
expansion of bulbar conjunctiva over the limbus, leads to
chronic irritation, impaired cosmesis, irregular astigmatism and decreased vision secondary to the development
of pupillary axis blockage by the increased growth.2
Different surgical techniques have been used for the
management of pterygium. The most common has been
the Ombrian's bare scleral excision technique.4
However, the major limitation to the success of the
technique has been the high rate of postoperative
recurrence associated with it.5
A number of adjunct therapies with varying levels of
reported successes have been used along with bare
scleral excision during the last three decades. Mitomycin-C
(MMC) as an adjunct therapy to bare sclera technique
was first introduced by Kunitomo and Mori of Japan.6
Further works on MMC usage in the USA by Singh and
associates led to its widespread use in Asia.7 A relatively
new method being used for pterygium management has
been the conjunctival autograft method. However, the
Section of Ophthalmology, Department of Surgery, The Aga Khan
University Hospital, Karachi.
Correspondence: Dr. P. Salim Mahar, 34/1, Khayaban-e-Mujahid,
Near 22nd Street, DHA, Phase V, Karachi.
E-mail: salim.mahar@aku.edu
Received January 15, 2011; accepted November 13, 2012.
120
METHODOLOGY
This case series study was carried out at Ophthalmology
Department, the Aga Khan University Hospital (AKUH),
Karachi, Pakistan from 2005 till 2010. The study protocol
was reviewed and approved by an ethics committee at
the study centre and the study was carried out in
accordance with the declaration of Helsinki of 1975 as
revised in 1983. The primary outcome measure was the
comparison of pterygium affected eye for any kind of
recurrence after excision along with the assessment of
Journal of the College of Physicians and Surgeons Pakistan 2013, Vol. 23 (2): 120-123
RESULTS
Number of patients
(N = 120)
Frequency
(%)
Right
53
44.2
Left
67
55.8
Affected eye
Site of pterygium
109
90.8
Temporal
Nasal
10
08.3
Central
01
0.83
Grading of pterygium*
Grade 1
85
70.8
Grade 2
20
16.7
Grade 3
15
12.5
Yes
08
06.7
No
112
93.3
Recurrence
Recurrence
N (%)
Yes
p-value*
No
Age (years)
Mean std. dev
0.14
42.4 1.23
< 50
07 (9.6)
66 (90.4)
> 50
01 (2.2)
46 (97.8)
Grade 1
01 (1.2)
84 (98.8)
Grade 2
04 (20.2)
16 (79.8)
Grading of pterygium
Grade 3
N = Number of subjects;
Journal of the College of Physicians and Surgeons Pakistan 2013, Vol. 23 (2): 120-123
03 (19.8)
* Fischer Exact test;
0.01
12 (80.2)
std. dev = Standard deviation;
min: minutes
121
DISCUSSION
Recurrence of pterygium remains an important health
care issue in ophthalmic patients worldwide,1 but
especially in tropical and Asian countries like Pakistan
due to high sun exposure coupled with increased rate of
air pollution and dusty weather. The present study was
motivated by the invariably high recurrence of pterygium
not only in Pakistan but world over.5,15
The recurrence rate of pterygium in the present study
was 6.7%. In a recent trial carried out in Pakistan,
Rahman et al. documented a recurrence of pterygium in
10% of the population. In a prospective study,16 Cheng
et al. observed a recurrence of 7.9% in subjects with
primary pterygia and a recurrence of 19.2% in subjects
with recurrent pterygia.17 In a study carried out by
Narsani et al. 6.97% recurrence was seen in primary
pterygia patients who underwent conjunctival autograft
as compared to 16.13% in patients treated by
intraoperative MMC.18 In contrast, Joseph et al. reported
a recurrence rate of 6.6% with intraoperative MMC as
compared to 13.3% in conjunctival autograft group.19 In
another study carried out by the author (PSM), 25.9%
recurrence was seen in conjunctival autograft group as
compared to 9.4% in the topical MMC group. Hence, the
authors preference for MMC based treatment for
patients was based on his own experience.20 However,
comparison between our study and others is likely to be
biased attributed to the different study population,
setting and criteria used for grading pterygium. Similar
conclusions have been drawn from numerous studies
carried throughout the globe.21,22 In this study, only male
patients with primary pterygium were enrolled for the
study and the intraoperative MMC application time was
also fixed at 3 minutes to limit the influence of factors
implicated in pterygium recurrence.5
A lot of grading systems are currently being used for
grading pterygium but in our study we have used the
grading system based on the size and extent of corneal
involvement by the fibrous pterygium. The same system
of grading is currently being used extensively in Asian
countries and some developed countries as well.3,13
There was a higher tendency of recurrence seen in
participants with higher grades of corneal involvement
with rate of recurrence of 1.2% in group grade 1 as
compared to 20.2% in group grade 2. Similar results
have been obtained in studies across Far East by Tan et
al., where a high rate of recurrence has been associated
with increased fleshiness of the pterygia,23 though the
grading system used in these studies is slightly different,
with translucency and vascularity being used as a
criterion for grading. Nonetheless it is a known fact that
translucency and vascularity increase with the increase
122
CONCLUSION
This study found a significant association of recurrence
with higher grade of corneal involvement by the
pterygium. This has important implications as early
excision of pterygium is not practiced even today until
the patient presents with disturbing visual symptoms.
Hence, early excision of pterygium is recommended to
decrease the recurrence rate of pterygium.
REFERENCES
1.
Ang LP, Chua JL, Tan DT. Current concepts and techniques in
pterygium treatment. Curr Opin Ophthalmol 2007; 18:308-13.
2.
3.
4.
5.
6.
7.
Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95:813-21.
Journal of the College of Physicians and Surgeons Pakistan 2013, Vol. 23 (2): 120-123
8.
9.
10. Qing-feng L, Liang X, Xiu-ying J, Qi-sheng Y, Xiao-hui Y, Tongtong C. Epidemiology of pterygium in aged rural population of
Beijing, China. Chinese Med J 2010; 123:1699-701.
11. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The
science of pterygia. Br J Ophthalmol 2010; 94:815-20.
12. Gazzard G, Saw SM, Farook M, Koh D, Widjaja D, Chia SE,
et al. Pterygium in Indonesia: prevalence, severity and risk
factors. Br J Ophthalmol 2002; 86):1341-6.
13. Maheshwari S. Pterygium induced: corneal refractive changes.
Indian J Ophthalmol 2007; 55:383-6.
14. Mahar PS, Nwokora GE. Role of mitomycin-C in pterygium
surgery. Br J Ophthalmol 1993; 77:433-5.
15. Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO.
Intraoperative mitomycin-C to prevent recurrence of pterygium
after excision: a 30-month follow-up study. Ophthalmology 1998;
105:901-4.
16. Rahman A, Yahya K, Sharif-ul-Hasan K. Recurrence rate of
pterygium following surgical excision with intraoperative versus
postoperative mitomycin-C. J Coll Physicians Surg Pak 2008;
18:489-92.
17. Cheng HC, Tseng SH, Kao PL, Chen FK. Low-dose intraoperative mitomycin-C as chemoadjuvant for pterygium surgery.
Cornea 2001; 20:24-9.
18. Narsani AK, Jatoi SM, Gul S, Dabir SA. Treatment of primary
Journal of the College of Physicians and Surgeons Pakistan 2013, Vol. 23 (2): 120-123
123